OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Roche Holding Ltd/  CH0012032113  /

Nasdaq Other OTC
2024-08-02  5:57:03 PM Chg. +12.0000 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
357.0000USD +3.48% 13
Turnover: 4,481.0800		 -Bid Size: - -Ask Size: - 303.26 bill.USD - -
TeleTrader 07-25 Europe lower premarket as earnings pour in
TeleTrader 07-25 Roche's H1 sales at 29.85 billion Swiss francs
GlobeNewswire 06-27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06-14 LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon...
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 05-27 Roche shuffles its executive committee
TeleTrader 05-16 Roche notes progress in obesity drug trial
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...
GlobeNewswire 05-07 Enable Injections Expands Strategic Partnership with Roche
TeleTrader 04-24 Roche's logs 14.4 billion Swiss francs in Q1 sales
GlobeNewswire 04-03 UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Inju...
GlobeNewswire 04-02 Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting C...
GlobeNewswire 03-22 HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highl...
GlobeNewswire 03-14 Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides C...
GlobeNewswire 02-26 Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...
GlobeNewswire 02-21 REPARE ALERT: Bragar Eagel & Squire, P.C. is Investigating Repare Therapeutics Inc. on Behalf of Rep...
TeleTrader 02-01 Roche's 2023 sales increase 1% to 58.7B Swiss francs
GlobeNewswire 01-29 Carmot Therapeutics Announces Completion of Acquisition by Roche
GlobeNewswire 01-03 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 01-03 Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Tria...
GlobeNewswire 2023-12-29 LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
GlobeNewswire 2023-12-14 Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibo...
GlobeNewswire 2023-12-13 U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Scler...
GlobeNewswire 2023-12-07 Industry Leader Greg Roche Joins Distalmotion as CEO